Lower limb amputations due to non-healing persistent diabetic foot ulcers (DFU) are becoming more common due to poorly controlled diabetes, infection, antibiotic resistance, and the ineffectiveness of current treatment approaches. Diabetes-based foot complications have affected millions of patients worldwide and have become a financial burden to developing countries as the cost of treatment is expensive, lengthy, and require extensive hospital admissions. The development of alternative treatment was unquestionably necessary given the profound severity of DFU complications. One of the ancient remedies which have re-emerged of late is honey as it has been proven to contain antibacterial, inflammatory, and moisturizing properties to enhance healing in chronic wounds. Currently, medical-grade manuka honey is being used in healthcare settings for the treatment of burns and wounds. Despite better antioxidant capacity and similar therapeutic qualities, stingless bee honey has received less attention in the field of chronic wound management. Therefore, this study was conducted to determine the efficacy of local stingless bee kelulut honey in the treatment of DFU. Thirty adult diabetic patients with chronic DFU participated in this experimental study, which was carried out in a tertiary hospital. Kelulut honey was applied to the wound and covered with a sterile gauze dressing. The dressing was changed every other day and observed for a week. Wound size was measured at baseline and the end of the one week. The outcome demonstrated a statistically significant percentage reduction in the wound size after one week, with no adverse effects noted and no de-sloughing being necessary during the one week. Hence, kelulut honey was concluded as a potential wound dressing that could be explored further to improve healing outcomes in DFU and prevent foot complications